However, in randomized clinical trials in type 2 diabetes, semaglutide resulted in up to 3 times greater weight loss compared with other GLP-1RAs and up to twice as much in patients with obesity, approaching 15 kg (35)
Everyones body is different
At Vytality Blu Health & Medspa, our healthcare team carefully assesses your overall treatment plan to avoid any drug interactions or complications
These medications work by mimicking the action of naturally occurring incretin hormones, which enhance glucose-dependent insulin secretion, suppress inappropriate glucagon release, slow gastric emptying, and promote satiety through central nervous system pathways
(Native, unmodified recombinant human IGF-1, sold as mecasermin/Increlex, is FDA-approved only for a narrow pediatric growth-failure indication and is chemically distinct from the LR3 analog.) In the US it is manufactured and sold almost exclusively as an unregulated "research chemical" labeled "not for human consumption," a labeling practice peptide vendors use to avoid marketing it as an unapproved drug